Mukka Proteins Limited (BOM:544135)
India · Delayed Price · Currency is INR 32.07
+1.67 (5.49%)
At close: Sep 11, 2026
Mukka Proteins Financials Overview
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Revenue Revenue Growth | 17,683 | 14,495 | 10,064 | 13,798 | 11,785 | 7,719 |
Revenue Growth | 76.01% | 44.02% | -27.06% | 17.08% | 52.67% | 27.68% |
Gross Profit Gross Profit Growth | 3,465 | 2,772 | 2,304 | 2,431 | 2,356 | 1,362 |
Operating Income Operating Income Growth | 1,299 | 1,005 | 832.36 | 959.17 | 761.01 | 414.97 |
Net Income Net Income Growth | 694.29 | 520.58 | 464.59 | 700.52 | 440.75 | 242.08 |
Earnings Per Share EPS Growth | 2.33 | 1.74 | 1.55 | 3.10 | 2.00 | 1.10 |
EPS Growth | 59.67% | 12.05% | -50.11% | 54.94% | 82.13% | 169.61% |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
India India Growth | 3,140 | 2,854 | 3,047 | 3,233 | 6,691 | 5,693 |
outside India outside India Growth | 13,524 | 11,181 | 6,753 | 10,188 | 4,873 | 1,964 |
Unallocated Unallocated Growth | - | 459.38 | 263.9 | - | - | 47.67 |
Total Total Growth | 16,663 | 14,495 | 10,064 | 13,421 | 11,564 | 7,705 |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Investments Cash & Investments Growth | 604.29 | 128.81 | 30.75 | 944.38 | 265.48 | 115.35 |
Total Debt Total Debt Growth | 7,793 | 7,793 | 4,529 | 3,653 | 2,622 | 1,754 |
Net Cash (Debt) Net Cash Growth | -7,189 | -7,664 | -4,498 | -2,708 | -2,356 | -1,639 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -24.10 | -25.55 | -14.99 | -12.00 | -10.71 | -7.45 |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Cash Flow Operating Cash Flow Growth | - | -1,113 | -1,119 | -1,504 | -563.28 | 48.08 |
Capital Expenditures CapEx Growth | - | -1,383 | -241.07 | -176.19 | -92.34 | -65.11 |
Free Cash Flow Free Cash Flow Growth | - | -2,495 | -1,360 | -1,680 | -655.62 | -17.03 |
Free Cash Flow Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Gross Margin | 19.59% | 19.13% | 22.89% | 17.62% | 19.99% | 17.64% |
Operating Margin | 7.34% | 6.93% | 8.27% | 6.95% | 6.46% | 5.38% |
Pretax Margin | 5.66% | 5.18% | 5.99% | 6.34% | 5.60% | 4.66% |
Profit Margin | 3.93% | 3.59% | 4.62% | 5.08% | 3.74% | 3.14% |
FCF Margin | - | -17.21% | -13.52% | -12.18% | -5.56% | -0.22% |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 12, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 13.90 | 10.66 | 21.09 | 15.63 | - | - |
PS Ratio | 0.55 | 0.38 | 0.97 | 0.79 | - | - |